Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102009060911Aexternal-prioritypatent/DE102009060911A1/de
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority claimed from PCT/EP2010/070502external-prioritypatent/WO2011080176A1/fr
Publication of MA33958B1publicationCriticalpatent/MA33958B1/fr
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
Y02E60/14—Thermal energy storage
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne de nouveaux composés hétérocycliques représentés par la formule (I), dans laquelle toutes les variables sont définies dans la spécification, sous forme libre ou sous forme de sel, leur préparation, leur utilisation médicale et des médicaments comprenant lesdits composés.
MA35108A2009-12-312010-12-22Derives de pyrazine et leur utilisation dans le traitement de troubles neurologiques
MA33958B1
(fr)